Pro-angiogenic therapeutics for preeclampsia
Abstract Preeclampsia is a pregnancy-induced hypertensive disorder resulting from abnormal placentation, which causes factors such as sFlt-1 to be released into the maternal circulation. Though anti-hypertensive drugs and magnesium sulfate can be given in an effort to moderate symptoms, the syndrome...
Main Authors: | Adrian C. Eddy, Gene L. Bidwell, Eric M. George |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Biology of Sex Differences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13293-018-0195-5 |
Similar Items
-
sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01) -
Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01) -
Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
by: Hiroaki Tanaka, et al.
Published: (2022-06-01) -
sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
by: Kamil Pluta, et al.
Published: (2024-01-01) -
sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2023-06-01)